Drugmakers Bet On Ebola Vaccines, Treatments

[Purveyor]

By MATTHEW PERRONE and DANICA KIRKA
Associated Press

Drugmakers are racing to develop vaccines and drugs to address the worst outbreak of Ebola in history. It's unclear who will pay for their products, but companies are betting that governments and aid groups will foot the bill.

There are no proven drugs or vaccines for Ebola, in large part because the disease is so rare that up until now it's been hard to attract research funding. And the West African nations hardest hit by the outbreak are unlikely to be able to afford new Ebola vaccines and drugs.

But governments and corporations now are shifting millions of dollars to fight Ebola in the wake of the outbreak that has infected nearly 10,000 people and killed over 4,800. Experts say drugmakers are wagering that international groups and wealthier governments like the U.S. will buy Ebola vaccines and drugs in mass quantities to stockpile them for future use once they're deemed safe.

"The political bet is that the U.S. and World Health Organization have been so embarrassed and burned by this event that they will be willing to change the way they do business," said Professor Lawrence Gostin of the Georgetown University Law School, who studies global health issues.

Drugmakers have benefited from stockpiling before. During the bird flu pandemic of 2009, Western governments spent billions to stock up on drugs and vaccines that mostly went unused. Shelf-life varies by product, but can be as little as a year.

more...

http://hosted.ap.org/dynamic/stories/U/US_EBOLA_PHARMA_OPPORTUNITY?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT&CTIME=2014-10-26-13-20-32

[customerserviceguy]

1. At least that's one positive effect of Ebola fear

At this point, I cannot imagine even the most knuckle-dragging Rethuglican opposing a bill to provide funding for treatments and vaccines.